Ovid Therapeutics Inc. Selling, General and Administrative Expense
Ovid Therapeutics Inc. (OVID) reported Selling, General and Administrative Expense of $2.98 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-06-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2017-06-13
- Ovid Therapeutics Inc. selling, general and administrative expense for the quarter ending 2017-03-31 was $2.98M, a 15.07% increase year-over-year.
- Ovid Therapeutics Inc. selling, general and administrative expense for the quarter ending 2016-03-31 was $2.59M.
| Period end | Selling, General and Administrative Expense 3 month |
|---|---|
| 2017-03-31 | $2.98M 10-Q · filed 2017-06-13 |
| 2016-03-31 | $2.59M 10-Q · filed 2017-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |